These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 62718)
1. Serum antibodies to herpesvirus early antigens in patients with cervical carcinoma determined by anticomplement immunofluorescence technique. Ito H; Tsutsui F; Kurihara S; Akabayashi T; Tobe T Int J Cancer; 1976 Nov; 18(5):557-63. PubMed ID: 62718 [TBL] [Abstract][Full Text] [Related]
2. Herpes virus-related antigens in herpes simplex virus type 2-transformed cells in the course of cervical carcinoma. Christenson B Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1345-52. PubMed ID: 6299751 [TBL] [Abstract][Full Text] [Related]
3. HSV 2-associated antigens in human cervical tissues before and after grafting in nude mice. Christenson B; Furgyik S Acta Obstet Gynecol Scand; 1983; 62(5):461-6. PubMed ID: 6320579 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells. Christenson B; Espmark A Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115 [TBL] [Abstract][Full Text] [Related]
5. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix. Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M Virologie; 1978; 29(4):251-3. PubMed ID: 219590 [TBL] [Abstract][Full Text] [Related]
6. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix. Thankamani V; Kumari TV; Vasudevan DM J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113 [TBL] [Abstract][Full Text] [Related]
7. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay. Jankowski MA; Petersen EE; Böcker JF Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235 [TBL] [Abstract][Full Text] [Related]
8. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer. Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337 [TBL] [Abstract][Full Text] [Related]
9. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2. Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764 [TBL] [Abstract][Full Text] [Related]
10. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand. Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050 [No Abstract] [Full Text] [Related]
11. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls. Feorino PM; Palmer EL J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521 [No Abstract] [Full Text] [Related]
12. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients. Ito H; Kurihara S; Nishimura C Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600 [No Abstract] [Full Text] [Related]
13. Herpes simplex virus and human cancer. III. Search for relationship of herpes simplex antibodies and cervical dysplasia and labial neoplasia. Rotola A; Gerna G; Di Luca D; Virgili AR; Manservigi R; Cassai E Tumori; 1983 Apr; 69(2):83-7. PubMed ID: 6304957 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus. Preissner CM; Steinberg SP; Gershon AA; Smith TF J Clin Microbiol; 1982 Aug; 16(2):373-6. PubMed ID: 6288766 [TBL] [Abstract][Full Text] [Related]
15. Humoral-and cell-mediated immune responses to herpesvirus antigens in patients with cervical carcinoma. Kumar A; Selim MS; Madden DL; Wallen WC; Vasquez HH; Nankervis GA Gynecol Oncol; 1980 Aug; 10(1):18-25. PubMed ID: 6249698 [No Abstract] [Full Text] [Related]
16. Anticomplement immunofluorescence for the titration of antibody to varicella-zoster virus. Shigeta S; Baba M; Ogata M; Iijima S; Murai C Microbiol Immunol; 1981; 25(3):295-303. PubMed ID: 6166838 [TBL] [Abstract][Full Text] [Related]
17. Detection of early antigens in nuclei of cells infected with cytomegalovirus or herpes simplex virus type 1 and 2 by anti-complement immunofluorescence, and use of a blocking assay to demonstrate their specificity. Giraldo G; Beth E; Hämmerling U; Tarro G; Kourilsky FM Int J Cancer; 1977 Jan; 19(1):107-16. PubMed ID: 64461 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi. Chiphangwi JD IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279 [TBL] [Abstract][Full Text] [Related]
19. Elution of herpes simplex virus-specific cytotoxic antibodies from squamous cell carcinoma of uterine cervix. Seth P; Balachandran N Nature; 1980 Aug; 286(5773):613-5. PubMed ID: 6250079 [TBL] [Abstract][Full Text] [Related]
20. Sero-immunological investigations in patients with cervical cancer: higher rate of HSV-2 antibodies than in syphilis patients and evidence of IgM antibodies to an early HSV-1 antigen. Schneweis KE; Haag A; Lehmköster A; Koenig U IARC Sci Publ (1971); 1975; (11 Pt 2):53-7. PubMed ID: 191383 [No Abstract] [Full Text] [Related] [Next] [New Search]